Research and laboratory use only. Not for human consumption.
GHK-Cu
GHK-Cu is a copper-binding complex formed by the naturally occurring human tripeptide GHK and a copper ion. It has been investigated for decades in tissue remodelling, extracellular-matrix biology, wound healing, skin ageing, cellular signalling and regenerative research.
What is GHK-Cu?
GHK is a naturally occurring human tripeptide consisting of the amino acids glycine, histidine and lysine . Its abbreviated amino-acid sequence is therefore GHK.
GHK has a strong affinity for copper ions and can form the coordination complex generally known as GHK-Cu.
The peptide was originally identified in human plasma during research into factors associated with differences between young and older tissue biology. Subsequent work established its three-amino-acid identity and copper-binding characteristics.
GHK has since been detected in biological fluids including plasma, saliva and urine and is associated with tissue injury and remodelling processes.
Scientific research has focused heavily on extracellular-matrix regulation, fibroblast activity, collagen and elastin, angiogenesis, inflammatory signalling, oxidative stress, skin remodelling and wound repair.
What does GHK-Cu mean?
The name is a direct description of the molecule.
GHK represents the one-letter amino-acid codes for glycine, histidine and lysine.
Cu is the chemical symbol for copper. GHK-Cu therefore describes the copper complex of the GHK tripeptide.
In cosmetic ingredient terminology, copper complexes based on GHK are also commonly described as Copper Tripeptide-1.
GHK and GHK-Cu are closely related but should not always be treated as completely interchangeable experimental materials, because the presence and coordination state of copper can influence biological and chemical behaviour.
Loren Pickart and colleagues reported a small plasma-derived factor capable of influencing protein synthesis and cellular behaviour. Later structural work identified the active peptide as glycyl-L-histidyl-L-lysine.
How was GHK discovered?
GHK research began during investigations into why human plasma from younger individuals appeared to influence cultured liver cells differently from plasma obtained from older individuals.
In 1973, Loren Pickart and colleagues reported a plasma-associated activity capable of influencing cell behaviour. Subsequent purification and structural research identified the active molecule as the tripeptide glycyl-L-histidyl-L-lysine .
Researchers later demonstrated that GHK binds copper strongly, leading to extensive investigation of the GHK-Cu complex.
One hypothesis is that GHK may participate in controlled copper transport and delivery during tissue remodelling, although the peptide's biological effects are broader than copper transport alone.
GHK and GHK-Cu are closely related — but not identical
GHK is the three-amino-acid peptide. GHK-Cu is a coordination complex formed when that peptide binds copper.
GHK
Glycyl-L-histidyl-L-lysine is the three-residue peptide itself.
GHK can exist without copper and has biological activity in its own right.
GHK-Cu
GHK coordinates copper through atoms within the peptide, creating the characteristic copper-peptide complex.
Much of the skin and tissue-remodelling literature discusses GHK-Cu specifically.
Published molecular formulae and molecular weights for GHK-Cu can differ depending on coordination state, charge, hydration and analytical representation. Compound-specific documentation should therefore define the exact material being studied.
Peptide sequence & copper coordination
GHK is among the shortest biologically active peptide sequences studied in humans, containing only three amino acids.
Why are researchers interested in GHK-Cu?
GHK-Cu has attracted unusually broad interest because it has been associated with several processes involved in tissue maintenance and remodelling.
Wound Repair
Laboratory, animal and limited human research has investigated GHK-Cu in processes associated with wound healing and re-epithelialisation.
Extracellular Matrix
Collagen, elastin, glycosaminoglycans, proteoglycans and matrix-remodelling enzymes have been important research targets.
Angiogenesis
Endothelial recruitment, growth-factor signalling and formation of new vascular structures have appeared in experimental tissue-repair research.
Oxidative & Inflammatory Biology
GHK-Cu has been investigated for effects on oxidative stress, inflammatory mediators and cellular protection.
How might GHK-Cu influence tissue biology?
GHK-Cu appears to interact with several biological systems rather than functioning through a single receptor mechanism.
Copper Binding
GHK strongly complexes copper, providing one proposed mechanism for regulated delivery of biologically useful copper during tissue remodelling.
Matrix Remodelling
Research has reported effects on collagen, elastin, glycosaminoglycans, metalloproteinases and their inhibitors.
Gene Expression
Transcriptomic analyses suggest GHK may alter expression patterns across numerous genes involved in repair, inflammation and cellular signalling.
Growth-Factor Biology
Experimental work has associated GHK-Cu with VEGF, fibroblast growth factors, nerve growth factors and related remodelling pathways.
Why is GHK-Cu so closely associated with skin?
Skin is one of the best-known areas of GHK-Cu research because skin remodelling requires many of the biological processes influenced experimentally by the peptide.
Controlled cosmetic studies summarized in the scientific literature have reported improvements in measures including skin firmness, elasticity, fine lines, photodamage and pigmentation.
These cosmetic findings should be distinguished from claims that GHK-Cu is an approved treatment for skin disease. Cosmetic use and therapeutic drug approval are different regulatory categories.
Interest has also extended to hair-follicle biology and post-procedure tissue remodelling, although the quality and scale of clinical evidence vary considerably between applications.
What could GHK-Cu eventually be investigated for?
GHK-Cu has stronger human dermatological experience than many experimental peptides, but proposed therapeutic applications still need to be separated from cosmetic and preclinical findings.
Acute Wound Repair
This area has now entered formal Phase 2 clinical research. A controlled study is evaluating topical GHK-Cu gel in standardized punch-biopsy wounds in healthy adults.
Skin Remodelling
Collagen, elastin, photodamage, skin density and pigmentation research makes topical dermatological use one of the most developed areas of GHK-Cu investigation.
Hair-Follicle Research
Experimental and limited clinical research has examined hair-follicle size, follicular biology and tissue remodelling around hair transplantation.
Broader Tissue Repair
Animal and laboratory findings involving nerves, bone, gastrointestinal tissues and other organs create research hypotheses for regenerative medicine, but clinical efficacy has not been established.
Evidence for topical cosmetic or topical clinical use cannot automatically be applied to injected or systemic GHK-Cu. Different routes require independent pharmacokinetic and safety evaluation.
How strong is the evidence?
GHK-Cu has a comparatively mature laboratory literature and some human topical evidence, but evidence strength differs greatly depending on the claimed application and route.
Molecular Evidence
Copper binding, extracellular-matrix regulation and cell-signalling effects have been studied extensively.
Animal Evidence
Numerous tissue-remodelling and wound-healing models have been reported across several species.
Human Topical Evidence
Human skin and cosmetic studies exist, although many are small and considerably less rigorous than large pharmaceutical trials.
Approved Therapeutic Drug
GHK-Cu is not established as an approved systemic regenerative medicine.
What do we currently know in humans?
Topical skin research is substantially more developed than evidence for injectable or systemic administration.
GHK-Cu differs from many research peptides because human topical and cosmetic experience already exists.
Reviews of controlled skin studies report changes in skin firmness, elasticity, density, fine lines, photodamage and other appearance-related endpoints following topical copper-peptide formulations.
Human research has also been reported in wound and tissue-remodelling contexts, although the available literature contains relatively few large modern randomized therapeutic trials.
Importantly, these findings should not be used as evidence that injected GHK-Cu is safe or effective. Injectable exposure has a different risk and pharmacokinetic profile and lacks the same clinical evidence base.
A new formal Phase 2 clinical trial has now begun evaluating topical GHK-Cu gel in standardized acute skin wounds, providing an opportunity for more rigorous controlled human evidence.
Where is GHK-Cu in clinical development?
The answer depends strongly on the formulation and intended route. Topical GHK-Cu has progressed into controlled clinical research, while injected research material should not be treated as an equivalent clinically validated product.
CuHeal
Phase 2 Clinical TrialA randomized, double-blind, vehicle-controlled split-wound study is investigating whether topical GHK-Cu gel can accelerate re-epithelialisation of standardized acute skin wounds in healthy adults.
What don't we know yet?
Factors affecting copper-peptide stability
Because GHK-Cu is both a peptide and a metal coordination complex, the precise chemical form, pH, solvent conditions and analytical specification are particularly relevant when evaluating research material.
Temperature
Temperature can influence peptide degradation and long-term chemical stability.
pH
Coordination chemistry and peptide stability can vary with solution pH.
Copper State
The copper-to-peptide ratio and coordination state should be defined in compound-specific analytical documentation.
Solution Conditions
Solvent, buffer, concentration and other components can influence metal-peptide chemistry and stability.
Topical clinical research underway — systemic therapeutic use not established
GHK-Cu is widely encountered in topical cosmetic formulations and has a substantial scientific literature relating to skin and tissue remodelling.
A Phase 2 trial is currently evaluating a specific topical GHK-Cu gel for acute skin wound healing. No results from that study are yet available.
This does not establish injected, systemic or other research forms of GHK-Cu as approved human medicines. Evidence and regulatory status must be evaluated separately for each formulation, route and intended use.
ASA Research Labs provides this information for scientific and educational purposes only. Nothing on this page provides instructions for administration, dosing or human use.
Selected scientific references
References are displayed directly on ASA Research without external links. They include foundational work, reviews of tissue remodelling and current clinical-development information.
Scientific research information only
This profile is provided for scientific and educational information. Discussion of GHK-Cu in skin biology, wound healing, collagen remodelling, hair research, ageing biology or clinical studies does not establish that every formulation or route of GHK-Cu is safe or effective for human treatment. Topical cosmetic and clinical evidence should not be extrapolated to injectable or systemic exposure. This page does not provide instructions for administration, dosing or human use.